enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Celecoxib - Wikipedia

   en.wikipedia.org/wiki/Celecoxib

   Celecoxib, sold under the brand name Celebrex among others, is a COX-2 inhibitor and nonsteroidal anti-inflammatory drug (NSAID). [7] It is used to treat the pain and inflammation in osteoarthritis, acute pain in adults, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, painful menstruation, and juvenile rheumatoid arthritis. [7]

3. Rofecoxib - Wikipedia

   en.wikipedia.org/wiki/Rofecoxib

   Only Celebrex (generic name is celecoxib) is still available for purchase in the United States. Regulatory authorities worldwide now require warnings about cardiovascular risk of COX-2 inhibitors still on the market.

4. Cyclooxygenase-2 inhibitor - Wikipedia

   en.wikipedia.org/wiki/Cyclooxygenase-2_inhibitor

   Celebrex (and other brand names for celecoxib) was introduced in 1999 and rapidly became the most frequently prescribed new drug in the United States. By October 2000, its US sales exceeded 100 million prescriptions per year for $3 billion, and was still rising. Sales of Celebrex alone reached $3.1 billion in 2001.

5. 3 Reasons Pfizer, Inc. Can Overcome Celebrex Patent Loss - AOL

   www.aol.com/news/2014-03-13-3-reasons-pfizer-inc...

   As Celebrex is Pfizer's fourth best-selling drug, raking in $2.9 billion in revenue in 2013 and showing stellar growth year over year of 9%, it's understandable if this court decision rattles ...

6. Pfizer Gets 18 More Months of Celebrex Patent Protection - AOL

   www.aol.com/news/2013-03-05-pfizer-gets-18-more...

   There's reason to celebrate for Celebrex. Pfizer announced today that the U.S. Patent and Trademark Office has added 18 months onto the pharmaceutical company's previous patent for the painkiller ...

7. Investors Don't Celebrate Celebrex Decision Favoring Cheap ...

   www.aol.com/news/2014-03-16-investors-dont...

   For premium support please call: 800-290-4726

8. List of largest selling pharmaceutical products - Wikipedia

   en.wikipedia.org/wiki/List_of_largest_selling...

   Rank Drug Trade name Type Main indications Company Sales (USD millions/year) ∆ vs 2014 1 Adalimumab: Humira Biologic Rheumatoid arthritis: AbbVie Inc. 14,012 1,469

9. Discovery and development of cyclooxygenase 2 inhibitors

   en.wikipedia.org/wiki/Discovery_and_development...

   [5] [6] It took less than eight years to develop and market the first COX-2 inhibitor, with Celebrex launched in December 1998 and Vioxx launched in May 1999. [ 7 ] [ 8 ] Celecoxib and other COX-2 selective inhibitors, valdecoxib , parecoxib , and mavacoxib , were discovered by a team at the Searle division of Monsanto led by John Talley .